The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
@EnergyShares - quality thanks for your input.
I'm sorry but so far but AS has been given the opportunity of a lifetime on a huge platter and has AS OF TODAY failed miserably to capitalise financially from it. He could win the euro millions and still end up in debt. He talks a good game (when you let him speak) but the proof is in the pudding as they say.
Of course I would have sold if the RNS's and interviews had represented accurately the position the company was in as I am sure many others would have done.
There was a window of opportunity that the company HAD to target but they missed it by a long shot, not just for the LFT but for sales to ensure they had cash for the clinical trials with mimimal/zero dilution. IT was that important - they should have thrown absolutely everything at it. Bragging they can create the reagents in a matter of weeks but then taking an eternity to get the product to market is absolutely laughable. "sale in the summer" a year out!
The market is now saturated, margins are low and it is almost impossible from websites to identify "the best test" because there is no set standards to compare them by. The company doesn't seem interested in addressing this either.
So far its just one bloke on the end of the telephone - not a good look.
Back at the placing price for a reason.
So the PCR testing system is under strain. Smith shelved BAMS because as always he was way behind the curve. Isn't now the scenario where BAMS would be in demand?
He really didnt put that 50 million to good use, yep he's got the bulk of it still in the kitty but just think where Avacta could have been now it they had used the cash to get things moving faster. Hes saved a couple of million to have missed out on potentially billions? Is that one of the qualities of a good CEO? No. Smith is an excellent scientist but has so far proved to be a shocking CEO who couldn't sell a lolly in the desert.
Same for Wilson.
Yep - investing based on information provided by the company via RNs's which unfortunately so far have proved to be way off the mark.
That is the problem here and investors have a right to be miffed at the rubbish that has been spouted by the CEO. Maybe you should take over the role, you had a good go at it last time. Do you know how to sell stuff?
Other than a webinar or two from the comfort of his own home what has he actually achieved?
Also when searching the multitude of LFT's available how does "the best test in the world" stand out against the competition? How has this not been in the media, articles written, interviews on prime time, how????? With the financing of the therapeutics relying on decent profits from LFT sales it's a ****ing pathetic attempt if you ask me, they have been given a dream opportunity on a ****ing plate and made an absolutely ****ing lash up of it.
If the chap from Canada is speaking to the company this week maybe its a subject he could bring up.
The BOD need to sell the story - interviews etc - get the word out about the wonderful assets they have that they picked up on the cheap.
Can sell up to 550K shares at the mo in one go.
Crazy this is still in the 7's should easily be above 15p.
Why oh why does everyone think Innova tests are brain ticklers??????
They are anterior nasal!!
Just inside the nose, the missus does them twice a week, still horrible though makes you sneeze and eyes water like ****.
Make that 157%!
Up 138% on the TSX!
Dont know the company but realistically what divi are you thinking here? Any calculations you would like to share?
Cheers
Kong1
Isn't it worse than that???
From the Nov RNS............."The performance of the test with clinical samples will now be evaluated as a precursor to a much larger clinical study with COVID-19 patients of known viral load to determine the clinical sensitivity of the test."
Have they started the "larger clinical study" yet? Alister bragging at the beginning it only took a few weeks for this that and the other....pointless if it then takes you years to get a product to market. Selling at the top with full knowledge they were having problems but giving the appearance that all was going swimmingly in interviews and RNS's saying it was
basically sorted and now in the hands of the 3rd parties.
Should be investigated if you ask me.